PIP anticorps (AA 51-146)
Aperçu rapide pour PIP anticorps (AA 51-146) (ABIN704231)
Antigène
Voir toutes PIP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 51-146
-
Réactivité croisée
- Humain
-
Homologie
- Mouse,Rat
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human GCDGP15/SABP
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- PIP (Prolactin-Induced Protein (PIP))
-
Sujet
-
Synonyms: GCDGP15, GCDGP 15, GCDGP-15, Gp17, GPIP4, Gross cystic disease fluid protein 15, Prolactin induced protein, Prolactin inducible protein precursor, SABP, Secretory actin binding protein.PIP_HUMAN
Background: Gross cystic disease is a common premenopausal disorder in which gross cysts are the predominant pathologic lesion. It is characterized by production of a fluid secretion which accumulates in the breast cysts. Gross cystic disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15 kDa monomer protein, GCDFP 15. The cells within the body that produce GCDFP 15 appear to be restricted primarily to those with apocrine function. Studies have found GCDFP 15 to be a highly specific and sensitive marker for breast cancer.
-
ID gène
- 5304
Antigène
-